PP
AGL icon

PDT Partners’s Agilon Health AGL Stock Holding History

PDT Partners’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,013
Closed -$198K – 704
2024
Q3 		$198K Sell
2,013
-12,363
-86% -$1.6M 0.02% 662
2024
Q2 		$2.35M Sell
14,376
-4,454
-24% -$635K 0.22% 165
2024
Q1 		$2.87M Buy
18,830
+11,285
+150% +$1.88M 0.27% 122
2023
Q4 		$2.37M Buy
7,545
+1,535
+26% +$556K 0.26% 118
2023
Q3 		$2.67M Buy
6,010
+4,404
+274% +$1.99M 0.34% 84
2023
Q2 		$696K Buy
1,606
+588
+58% +$330K 0.1% 327
2023
Q1 		$604K Sell
1,018
-5,063
-83% -$2.84M 0.08% 362
2022
Q4 		$2.45M Sell
6,081
-239
-4% -$112K 0.4% 56
2022
Q3 		$3.7M Sell
6,320
-2,712
-30% -$1.62M 0.56% 4
2022
Q2 		$4.93M Buy
9,032
+5,124
+131% +$2.59M 0.43% 21
2022
Q1 		$2.48M Sell
3,908
-2,492
-39% -$1.28M 0.21% 130
2021
Q4 		$4.32M Buy
+6,400
New +$3.89M 0.33% 79

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PDT Partners's AGL Position: Q4 2024 in Review

PDT Partners sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 2,013 shares — an estimated $198K sold.

PDT Partners first reported a position in AGL in Q4 2021 and held it in 12 quarters. The position peaked at $4.93M in Q2 2022. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • PDT Partners reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • PDT Partners sold 2,013 Agilon Health shares in Q4 2024, an estimated $198K.
  • PDT Partners first reported a position in Agilon Health in Q4 2021 and held it in 12 quarters.
  • PDT Partners's Agilon Health position peaked at $4.93M in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.